Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Welch

Showing results (371-380 of 383) with videos related to

Pageof 39
Sort By:
HIV Medicine|February 5, 2015
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult lifeA Bamford, A Turkova, H Lyall, et al.
HIV Medicine|October 24, 2024
HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta surveyGeorgina Fernandes, Elizabeth Chappell, Tessa Goetghebuer, et al.
Plos One|April 24, 2018
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L Moore, Karina Butler, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2James F Blake, John J Gaudino, Jason De Meese, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2016
Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory diseaseQing Zhou, Xiaomin Yu, Erkan Demirkaya, et al.
The Lancet. Child & Adolescent Health|January 24, 2026
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trialAnna Turkova, Ellen White, Avy Violari, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 16, 2021
SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System SyndromeMarisol Perez-Toledo, Sian E Faustini, Sian E Jossi, et al.
The Lancet. Child & Adolescent Health|June 29, 2020
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort studyFlorian Götzinger, Begoña Santiago-García, Antoni Noguera-Julián, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
Eclinicalmedicine|June 12, 2023
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trialAlexandra Compagnucci, Man K Chan, Yacine Saïdi, et al.
Pageof 39

Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
HIV Medicine|February 5, 2015
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult lifeA Bamford, A Turkova, H Lyall, et al.
HIV Medicine|October 24, 2024
HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta surveyGeorgina Fernandes, Elizabeth Chappell, Tessa Goetghebuer, et al.
Plos One|April 24, 2018
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L Moore, Karina Butler, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2014
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2James F Blake, John J Gaudino, Jason De Meese, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 2016
Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory diseaseQing Zhou, Xiaomin Yu, Erkan Demirkaya, et al.
The Lancet. Child & Adolescent Health|January 24, 2026
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trialAnna Turkova, Ellen White, Avy Violari, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 16, 2021
SARS-CoV-2-specific IgG1/IgG3 but not IgM in children with Pediatric Inflammatory Multi-System SyndromeMarisol Perez-Toledo, Sian E Faustini, Sian E Jossi, et al.
The Lancet. Child & Adolescent Health|June 29, 2020
COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort studyFlorian Götzinger, Begoña Santiago-García, Antoni Noguera-Julián, et al.
The New England Journal of Medicine|March 9, 2022
Shorter Treatment for Nonsevere Tuberculosis in African and Indian ChildrenAnna Turkova, Genevieve H Wills, Eric Wobudeya, et al.
Eclinicalmedicine|June 12, 2023
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trialAlexandra Compagnucci, Man K Chan, Yacine Saïdi, et al.
Pageof 39